Unknown NA INTERVENTIONAL 2-arm NCT04643054

Efficacy and Safety of Ovotransferrin in COVID-19 Patients

Efficacy and Safety of Ovotransferrin in COVID-19 Patients With Mild-to-Moderate Disease

Sponsor: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

Conditions Covid19

Updated 5 times since 2020 Last updated: Nov 23, 2020 Started: Dec 1, 2020 Primary completion: Feb 28, 2021 Completion: Mar 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04643054, this NA trial focuses on Covid19 and remains ongoing. Sponsored by Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Not Yet Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

Data source: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palermo, Italy